TVPills

Boehringer Ingelheim/Eli Lilly Drugs Advertised on TV

3 prescription medications from Boehringer Ingelheim/Eli Lilly seen in TV advertising, with an estimated $337M in combined annual ad spend. Ranked by ad spend.

Share
US Jardiance

empagliflozin · Type 2 diabetes, heart failure, chronic kidney disease

$280M CostDetails
CA Jardiance

empagliflozin · Type 2 diabetes, heart failure, chronic kidney disease

$55M CostDetails
NZ Jardiance

empagliflozin · Type 2 diabetes, heart failure

$2M CostDetails

Frequently asked questions

What drugs does Boehringer Ingelheim/Eli Lilly advertise on TV?

Jardiance, Jardiance, Jardiance are among the Boehringer Ingelheim/Eli Lilly medications TVPills tracks in TV advertising — 3 in total.

Which Boehringer Ingelheim/Eli Lilly drug spends the most on TV advertising?

Jardiance (empagliflozin) leads Boehringer Ingelheim/Eli Lilly's TV-advertised lineup with an estimated $280M in annual ad spend.

What conditions do Boehringer Ingelheim/Eli Lilly drugs treat?

The Boehringer Ingelheim/Eli Lilly drugs we track are advertised for Diabetes.

Is a Boehringer Ingelheim/Eli Lilly drug right for me?

TVPills is an informational reference, not medical advice. Only a licensed healthcare provider can recommend whether a Boehringer Ingelheim/Eli Lilly medication is right for your situation.

TVPills

A reference tool to help identify prescription medications and supplements seen in television advertising. This is not medical advice. Always consult a healthcare professional.

TVPills is independent and not affiliated with, endorsed by, or sponsored by any drug manufacturer or brand. All trademarks are the property of their respective owners. Some links are affiliate links; we may earn a commission at no extra cost to you.